Cargando…

A magnetic bead immunoassay to detect high affinity human IgG reactive to SARS-CoV-2 Spike S1 RBD produced in Escherichia coli

Immunological assays to detect SARS-CoV-2 Spike Receptor Binding Domain (RBD) antigen seroconversion in humans are important tools to monitor the levels of protecting antibodies in the population in response to infection and/or immunization. Here we describe a simple, low cost, and high throughput N...

Descripción completa

Detalles Bibliográficos
Autores principales:	Conzentino, Marcelo S., Gonçalves, Ana C. A., Paula, Nigella M., Rego, Fabiane G. M., Zanette, Dalila L., Aoki, Mateus N., Nardin, Jeanine M., Huergo, Luciano Fernandes
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2022
Materias:	Clinical Microbiology - Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9009495/ https://www.ncbi.nlm.nih.gov/pubmed/35426068 http://dx.doi.org/10.1007/s42770-022-00753-x

Ejemplares similares

Ultra-fast, high throughput and inexpensive detection of SARS-CoV-2 seroconversion using Ni(2+) magnetic beads
por: Conzentino, Marcelo S., et al.
Publicado: (2021)

Antigen production and development of an indirect ELISA based on the nucleocapsid protein to detect human SARS-CoV-2 seroconversion
por: Conzentino, Marcelo S., et al.
Publicado: (2021)

Multiepitope Proteins for the Differential Detection of IgG Antibodies against RBD of the Spike Protein and Non-RBD Regions of SARS-CoV-2
por: Gomes, Larissa R., et al.
Publicado: (2021)

Anti-spike S1 IgA, anti-spike trimeric IgG, and anti-spike RBD IgG response after BNT162b2 COVID-19 mRNA vaccination in healthcare workers
por: Salvagno, Gian Luca, et al.
Publicado: (2021)

Prevalent, protective, and convergent IgG recognition of SARS-CoV-2 non-RBD spike epitopes
por: Voss, William N., et al.
Publicado: (2021)

Multiplex Immunoassays: Chips and Beads
por: Vostrý, Michal
Publicado: (2010)

Interface-Based Design of High-Affinity Affibody Ligands for the Purification of RBD from Spike Proteins
por: Song, Siyuan, et al.
Publicado: (2023)

Essential properties and pitfalls of colorimetric Reverse Transcription Loop-mediated Isothermal Amplification as a point-of-care test for SARS-CoV-2 diagnosis
por: de Oliveira Coelho, Bruna, et al.
Publicado: (2021)

Immunoassay for quantification of antigen-specific IgG fucosylation
por: Šuštić, Tonći, et al.
Publicado: (2022)

Levels of SARS-COV-2 anti-spike protein receptor-binding domain (S-RBD) IgG in Indonesian-vaccinated healthcare workers: experimental research
por: Tambunan, Betty A., et al.
Publicado: (2023)

Bead Number Effect in a Magnetic-Beads-Based Digital Microfluidic Immunoassay
por: Hsu, Wensyang, et al.
Publicado: (2022)

RBD and Spike DNA-Based Immunization in Rabbits Elicited IgG Avidity Maturation and High Neutralizing Antibody Responses against SARS-CoV-2
por: da Costa, Hernan H. M., et al.
Publicado: (2023)

Mutational scanning of spike RBD protein for enhanced ACE2 affinity emerging Southeast Asia in the late transmission phase
por: Kodchakorn, Kanchanok, et al.
Publicado: (2022)

SARS-CoV-2 spike RBD-specific IgA and IgG antibodies in breast milk after vaccination with the protein subunit vaccine Abdala
por: Pérez-Bernal, Maylin, et al.
Publicado: (2022)

Evaluation of a New Spike (S)-Protein-Based Commercial Immunoassay for the Detection of Anti-SARS-CoV-2 IgG
por: Eberhardt, Kirsten Alexandra, et al.
Publicado: (2021)

A novel bead-based fluorescence immunoassay for aldosterone
por: Sun, Min, et al.
Publicado: (2011)

Detection of SARS-CoV-2 IgG Targeting Nucleocapsid or Spike Protein by Four High-Throughput Immunoassays Authorized for Emergency Use
por: Prince, Harry E., et al.
Publicado: (2020)

Molecular dynamics study on the strengthening behavior of Delta and Omicron SARS-CoV-2 spike RBD improved receptor-binding affinity
por: Kodchakorn, Kanchanok, et al.
Publicado: (2022)

Comparison of pre-processing methods for multiplex bead-based immunoassays
por: Rausch, Tanja K., et al.
Publicado: (2016)

Rapid Multianalyte Microfluidic Homogeneous Immunoassay on Electrokinetically Driven Beads
por: Thiriet, Pierre-Emmanuel, et al.
Publicado: (2020)

Single-Color Barcoding for Multiplexed Hydrogel Bead-Based Immunoassays
por: Weber, Tobias A., et al.
Publicado: (2022)

Evolution of Anti-RBD IgG Avidity following SARS-CoV-2 Infection
por: Tauzin, Alexandra, et al.
Publicado: (2022)

Multiplex Microsphere Immunoassays for the Detection of IgM and IgG to Arboviral Diseases
por: Basile, Alison J., et al.
Publicado: (2013)

Comparable diagnostic accuracy of SARS-CoV-2 Spike RBD and N-specific IgG tests to determine pre-vaccination nation-wide baseline seroprevalence in Mexico
por: Martínez-Barnetche, Jesús, et al.
Publicado: (2022)

Development and evaluation of a low cost IgG ELISA test based in RBD protein for COVID-19
por: Villafañe, Luciana, et al.
Publicado: (2022)

Preliminary multiplex microarray IgG immunoassay for the diagnosis of toxoplasmosis and rubella
por: Baschirotto, Priscila T, et al.
Publicado: (2017)

Effects of common mutations in the SARS-CoV-2 Spike RBD and its ligand, the human ACE2 receptor on binding affinity and kinetics
por: Barton, Michael I, et al.
Publicado: (2021)

Computational prediction of the effect of amino acid changes on the binding affinity between SARS-CoV-2 spike RBD and human ACE2
por: Chen, Chen, et al.
Publicado: (2021)

A CNN model for predicting binding affinity changes between SARS-CoV-2 spike RBD variants and ACE2 homologues
por: Chen, Chen, et al.
Publicado: (2022)

Optimisation and Validation of a conventional ELISA and cut-offs for detecting and quantifying anti-SARS-CoV-2 Spike, RBD, and Nucleoprotein IgG, IgM, and IgA antibodies in Uganda
por: Oluka, Gerald Kevin, et al.
Publicado: (2023)

A rapid magnetic bead-based immunoassay for sensitive determination of diclofenac
por: Ecke, Alexander, et al.
Publicado: (2021)

Optimising a 6-plex tetanus-diphtheria-pertussis fluorescent bead-based immunoassay
por: McAlister, Sonia M., et al.
Publicado: (2021)

Simultaneous Measurement of IgM and IgG Antibodies to SARS-CoV-2 Spike, RBD, and Nucleocapsid Multiplexed in a Single Assay on the xMAP INTELLIFLEX DR-SE Flow Analyzer
por: Cameron, Andrew, et al.
Publicado: (2022)

Natural IgG against S-Protein and RBD of SARS-CoV-2 Do Not Bind and Hydrolyze DNA and Are Not Autoimmune
por: Timofeeva, Anna M., et al.
Publicado: (2022)

Electrostatic Interactions Are the Primary Determinant of the Binding Affinity of SARS-CoV-2 Spike RBD to ACE2: A Computational Case Study of Omicron Variants
por: Sang, Peng, et al.
Publicado: (2022)

Coronavirus Disease 2019-Related Alterations of Total and Anti-Spike IgG Glycosylation in Relation to Age and Anti-Spike IgG Titer
por: Schwedler, Christian, et al.
Publicado: (2022)

Detection of Anti-SARS-CoV-2-S2 IgG Is More Sensitive Than Anti-RBD IgG in Identifying Asymptomatic COVID-19 Patients
por: Liao, Baolin, et al.
Publicado: (2021)

Development of a multiplexed bead-based immunoassay for the simultaneous detection of antibodies to 17 pneumococcal proteins
por: Shoma, S., et al.
Publicado: (2010)

Landscape of the RBD-specific IgG, IgM, and IgA responses triggered by the inactivated virus vaccine against the Omicron variant
por: Xue, Jun-biao, et al.
Publicado: (2022)

Reversal of the unique Q493R mutation increases the affinity of Omicron S1-RBD for ACE2
por: Philip, Angelin M., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_cq8j5di4vm895k7c5ivt2tmmtc